đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
Peripherally Inserted Central Catheters (PICCs) are commonly used in patien...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-03
Trial ID
NCT04281524
This study is designed to evaluate the safety after switching to garadacima...
Status
Completed
Location
Research Solutions of Arizona
Start Date
2025-04-28
Trial ID
NCT06806657
Treatments Being Tested
This phase 3b study will evaluate long-term safety and efficacy of CSL312 (...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2021-03-29
Trial ID
NCT04739059
Treatments Being Tested
This is a multicenter, double-blind, randomized, placebo-controlled, parall...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2021-01-27
Trial ID
NCT04656418
This is a multicenter, randomized, placebo-controlled, parallel-arm, phase ...
Status
Completed
Location
Donald S. Levy
Start Date
2018-10-29
Trial ID
NCT03712228
Treatments Being Tested
This will be a 2- part, phase 1, open-label, single center, single ascendin...
Status
Completed
Location
Anaheim Clinical Trials, LLC
Start Date
2020-10-29
Trial ID
NCT04580654
Treatments Being Tested
This protocol for post study access allows pediatric participants (2-11 yea...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT07159464
Treatments Being Tested
This is a prospective, phase 2, multicenter, randomized, double blind, plac...
Status
Completed
Location
Nova Clinical Research, LLC
Start Date
2020-07-01
Trial ID
NCT04409509
Treatments Being Tested
This is an open-label, parallel-group, phase 1, single center study to asse...
Status
Completed
Location
Anaheim Clinical Trials, LLC
Start Date
2022-04-04
Trial ID
NCT05306275
Treatments Being Tested
This is a prospective, phase 2a, multicenter, randomized, double-blind, pla...
Status
Completed
Location
The University of Alabama at Birmingham
Start Date
2022-02-03
Trial ID
NCT05130970
Treatments Being Tested